Literature DB >> 15050251

High-order aberrations in pseudophakia with different intraocular lenses.

Lucas Vilarrodona1, Graham D Barrett, Bradley Johnson.   

Abstract

PURPOSE: To compare high-order aberrations in patients who had cataract surgery and implantation of different types of intraocular lenses (IOLs).
SETTING: Sir Charles Gairdner Hospital and Lions Eye Institute, University of Western Australia, Perth, Australia.
METHODS: Fifty eyes of 48 patients were included in this study. The optical aberrations were measured with the Hartmann-Shack wavefront sensor (Zyoptix, Bausch & Lomb) before and after surgery using a 5.0 mm wavefront aperture diameter for all comparisons. The eyes were divided into 4 groups according to the type of IOL (material and curvature). A fifth group of 10 eyes of 6 elderly patients with normal crystalline lenses had the same examination.
RESULTS: There was no statistical difference in high-order aberrations between the 2 acrylic IOL groups with different curvatures (P>.05) or between the silicone and poly(methyl methacrylate) (PMMA) IOL groups (P>.05). However, the measured high-order aberrations were significantly higher (3rd through 5th order) in the 2 acrylic IOL groups than in the PMMA and silicone IOL groups (P<.05).
CONCLUSIONS: An increase in IOL high-order aberrations contributed to the decline in retinal image quality. An IOL modifies the entire aberration pattern of the eye. There was a statistically significant increase in aberrations in patients with an acrylic IOL compared to those with a silicone or PMMA IOL. The exact mechanism is uncertain. Further study is required to optimize IOL design.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050251     DOI: 10.1016/j.jcrs.2003.12.041

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Star testing: a novel evaluation of intraocular lens optical quality.

Authors:  L Mitchell; A C B Molteno; T H Bevin; G Sanderson
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Comparison of contrast sensitivity, depth of field and ocular wavefront aberrations in eyes with an IOL with zero versus positive spherical aberration.

Authors:  Jay S Pepose; Mujtaba A Qazi; Keith H Edwards; Jeff P Sanderson; Edwin J Sarver
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-11       Impact factor: 3.117

3.  Wavefront analysis of acrylic spherical and aspherical intraocular lenses.

Authors:  Satoru Takeo; Yoichiro Watanabe; Misa Suzuki; Kazuaki Kadonosono
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

4.  Comparative study of visual function and ocular aberrations of two different one-piece designed hydrophilic acrylic intraocular lens.

Authors:  Yuxin Zhao; Zhaoxia Wang; Xia Tian; Xuehong Wang; Xining Gao
Journal:  Int Ophthalmol       Date:  2017-05-30       Impact factor: 2.031

5.  Influence of tilt and decentration of scleral-sutured intraocular lens on ocular higher-order wavefront aberration.

Authors:  T Oshika; G Sugita; K Miyata; T Tokunaga; T Samejima; C Okamoto; Y Ishii
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

6.  Comparing the effect of two different intraocular lenses on optical aberrations in bilaterally operated eyes for cataract.

Authors:  Esra Ayhan Tuzcu; Kuddusi Erkilic; Betul Bulut; Nilufer Ilhan
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

7.  Optical aberrations, accommodation, and visual acuity with a bioanalogic continuous focus intraocular lens after cataract surgery.

Authors:  Heidar Siatiri; Mehrdad Mohammadpour; Afsaneh Gholami; Elham Ashrafi; Nassim Siatiri; Reza Mirshahi
Journal:  J Curr Ophthalmol       Date:  2017-07-29

8.  Long-Term Evaluation of Visual Outcomes and Patient Satisfaction after Binocular Implantation of a Bioanalogic Lens.

Authors:  Sylwia Wagner; Grzegorz Wagner; Ewa Mrukwa-Kominek
Journal:  J Ophthalmol       Date:  2021-05-07       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.